PB1972: ASC4START: A PHASE IIIB, OPEN-LABEL, RANDOMIZED STUDY OF ASCIMINIB VERSUS NILOTINIB IN PATIENTS WITH NEWLY DIAGNOSED PH+ CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE

por Hochhaus, Andreas, Saussele, Susanne, Mahon, Francois-Xavier, Pilipovic, Virginia, Zhang, Yifan, Schuld, Peter, Brümmendorf, Tim H
Publicado 2023

P668: CHRONIC MYELOID LEUKEMIA SURVEY ON UNMET NEEDS (CML SUN): BALANCING TOLERABILITY AND EFFICACY GOALS OF PATIENTS AND PHYSICIANS THROUGH SHARED TREATMENT DECISION-MAKING

por Lang, Fabian, Pemberton-Whiteley, Zack, Clements, Joannie, Ruiz, Cristina, Rea, Delphine, Machado, Lisa, Takahashi, Naoto, Moon, Sung-Ho, P Grigg, Andrew, Borowczak, Cornelia, Schuld, Peter, Frank, Pauline, Constantinescu, Cristina, Boquimpani, Carla, Cortes, Jorge
Publicado 2023